John Haserick
Company: Innovac Therapeutics
Job title: Vice President Of Platform Development
Seminars:
Ensuring Excellence: Quality Control of Raw & Starting Materials for mRNA-Based Therapeutics 11:00 am
What specific attributes of mRNA raw materials are evaluated during quality control processes, and how do these attributes influence the safety and efficacy of the final product? What are the established regulatory guidelines for quality control of mRNA raw materials? What strategies are being explored to address challenges related to batch-to-batch variability and quality assurance? Read more
day: Day One